Nasal Vaccines  Market Report

Global Nasal Vaccines Market Study Report 2022 Historical Trends, Growth, and Forecast to 2028

  • POSTDATE：Feb 24, 2022
  • PAGES：166
  • REPORT CODE：GMM772969
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • Nasal Vaccines market report explains the definition, types, applications, major countries, and major players of the Nasal Vaccines market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.

    The report contains qualitative and quantitative analysis of the entire industry.

    The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.

    By Player:

    • Serum Institute of India

    • GlaxoSmithKline

    • Bharat Biotech

    • PharmaJet and Crossject

    • BioDiem

    • Abbott

    • AstraZeneca

    • Antares Pharma

    • Sanofi

    • INJEX Pharma GmbH

    By Type:

    • Flu Vaccines

    • COVID-19 Vaccines

    • Other Vaccines

    By End-User:

    • Adult

    • Children

    By Region:

    North America

    • United States

    • Canada

    • Mexico

    Europe

    • Germany

    • UK

    • Spain

    • France

    • Italy

    • Denmark

    • Finland

    • Norway

    • Sweden

    • Poland

    • Russia

    • Turkey

    Asia-Pacific

    • China

    • Japan

    • India

    • South Korea

    • Pakistan

    • Bangladesh

    • Indonesia

    • Thailand

    • Singapore

    • Malaysia

    • Philippines

    • Vietnam

    • Others

    South America

    • Brazil

    • Colombia

    • Chile

    • Argentina

    • Venezuela

    • Peru

    • Puerto Rico

    • Ecuador

    • Others

    GCC

    • Bahrain

    • Kuwait

    • Oman

    • Qatar

    • Saudi Arabia

    • United Arab Emirates

    Africa

    • Nigeria

    • South Africa

    • Egypt

    • Algeriat

    • Others

    Oceania

    • Australia

    • New Zealand

  • TABLE OF CONTENT

    1. Global Nasal Vaccines Executive Summary

    • 1.1 Introduction

    • 1.2 Market Panorama, 2022

    2 Coronavirus Impact

    • 2.1 Nasal Vaccines Outlook to 2028- Original Forecasts

    • 2.2 Nasal Vaccines Outlook to 2028- COVID-19 Affected Forecasts

    • 2.3 Impact on Industry

    3 Strategic Analytics to Boost Productivity and Profitability

    • 3.1 Potential Market Drivers and Opportunities

    • 3.2 New Challenges and Strategies

    • 3.3 Short Term and Long Term Nasal Vaccines Market Trends

    4 Key Inferences

    5 Market Overview

    • 5.1 Current Market Scenario

    • 5.2 Porter's Five Forces Analysis

      • 5.2.1 Bargaining Power of Suppliers

      • 5.2.2 Bargaining Power of Consumers

      • 5.2.3 Threat of New Entrants

      • 5.2.4 Threat of Substitute Product and Services

      • 5.2.5 Competitive Rivalry within the Industry

    6 Global Nasal Vaccines Market- Recent Developments

    • 6.1 Nasal Vaccines Market News and Developments

    • 6.2 Nasal Vaccines Market Deals Landscape

    7 Nasal Vaccines Raw Materials and Cost Structure Analysis

    • 7.1 Nasal Vaccines Key Raw Materials

    • 7.2 Nasal Vaccines Price Trend of Key Raw Materials

    • 7.3 Nasal Vaccines Key Suppliers of Raw Materials

    • 7.4 Nasal Vaccines Market Concentration Rate of Raw Materials

    • 7.5 Nasal Vaccines Cost Structure Analysis

      • 7.5.1 Nasal Vaccines Raw Materials Analysis

      • 7.5.2 Nasal Vaccines Labor Cost Analysis

      • 7.5.3 Nasal Vaccines Manufacturing Expenses Analysis

    8 Global Nasal Vaccines Import and Export Analysis (Top 10 Countries)

    • 8.1 Global Nasal Vaccines Import by Region (Top 10 Countries) (2017-2028)

    • 8.2 Global Nasal Vaccines Export by Region (Top 10 Countries) (2017-2028)

    9 Global Nasal Vaccines Market Outlook by Types and Applications to 2022

    • 9.1 Global Nasal Vaccines Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Flu Vaccines Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global COVID-19 Vaccines Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Other Vaccines Consumption and Growth Rate (2017-2022)

    • 9.2 Global Nasal Vaccines Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Adult Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Children Consumption and Growth Rate (2017-2022)

    10 Region and Country-wise Nasal Vaccines Market Analysis and Outlook till 2022

    • 10.1 Global Nasal Vaccines Consumption (2017-2022)

    • 10.2 North America Consumption Analysis

      • 10.2.1 United States Nasal Vaccines Consumption (2017-2022)

      • 10.2.2 Canada Nasal Vaccines Consumption (2017-2022)

      • 10.2.3 Mexico Nasal Vaccines Consumption (2017-2022)

    • 10.3 Europe Consumption Analysis

      • 10.3.1 Germany Nasal Vaccines Consumption (2017-2022)

      • 10.3.2 UK Nasal Vaccines Consumption (2017-2022)

      • 10.3.3 Spain Nasal Vaccines Consumption (2017-2022)

      • 10.3.4 Belgium Nasal Vaccines Consumption (2017-2022)

      • 10.3.5 France Nasal Vaccines Consumption (2017-2022)

      • 10.3.6 Italy Nasal Vaccines Consumption (2017-2022)

      • 10.3.7 Denmark Nasal Vaccines Consumption (2017-2022)

      • 10.3.8 Finland Nasal Vaccines Consumption (2017-2022)

      • 10.3.9 Norway Nasal Vaccines Consumption (2017-2022)

      • 10.3.10 Sweden Nasal Vaccines Consumption (2017-2022)

      • 10.3.11 Poland Nasal Vaccines Consumption (2017-2022)

      • 10.3.12 Russia Nasal Vaccines Consumption (2017-2022)

      • 10.3.13 Turkey Nasal Vaccines Consumption (2017-2022)

    • 10.4 APAC Consumption Analysis

      • 10.4.1 China Nasal Vaccines Consumption (2017-2022)

      • 10.4.2 Japan Nasal Vaccines Consumption (2017-2022)

      • 10.4.3 India Nasal Vaccines Consumption (2017-2022)

      • 10.4.4 South Korea Nasal Vaccines Consumption (2017-2022)

      • 10.4.5 Pakistan Nasal Vaccines Consumption (2017-2022)

      • 10.4.6 Bangladesh Nasal Vaccines Consumption (2017-2022)

      • 10.4.7 Indonesia Nasal Vaccines Consumption (2017-2022)

      • 10.4.8 Thailand Nasal Vaccines Consumption (2017-2022)

      • 10.4.9 Singapore Nasal Vaccines Consumption (2017-2022)

      • 10.4.10 Malaysia Nasal Vaccines Consumption (2017-2022)

      • 10.4.11 Philippines Nasal Vaccines Consumption (2017-2022)

      • 10.4.12 Vietnam Nasal Vaccines Consumption (2017-2022)

    • 10.5 South America Consumption Analysis

      • 10.5.1 Brazil Nasal Vaccines Consumption (2017-2022)

      • 10.5.2 Colombia Nasal Vaccines Consumption (2017-2022)

      • 10.5.3 Chile Nasal Vaccines Consumption (2017-2022)

      • 10.5.4 Argentina Nasal Vaccines Consumption (2017-2022)

      • 10.5.5 Venezuela Nasal Vaccines Consumption (2017-2022)

      • 10.5.6 Peru Nasal Vaccines Consumption (2017-2022)

      • 10.5.7 Puerto Rico Nasal Vaccines Consumption (2017-2022)

      • 10.5.8 Ecuador Nasal Vaccines Consumption (2017-2022)

    • 10.6 GCC Consumption Analysis

      • 10.6.1 Bahrain Nasal Vaccines Consumption (2017-2022)

      • 10.6.2 Kuwait Nasal Vaccines Consumption (2017-2022)

      • 10.6.3 Oman Nasal Vaccines Consumption (2017-2022)

      • 10.6.4 Qatar Nasal Vaccines Consumption (2017-2022)

      • 10.6.5 Saudi Arabia Nasal Vaccines Consumption (2017-2022)

      • 10.6.6 United Arab Emirates Nasal Vaccines Consumption (2017-2022)

    • 10.7 Africa Consumption Analysis

      • 10.7.1 Nigeria Nasal Vaccines Consumption (2017-2022)

      • 10.7.2 South Africa Nasal Vaccines Consumption (2017-2022)

      • 10.7.3 Egypt Nasal Vaccines Consumption (2017-2022)

      • 10.7.4 Algeria Nasal Vaccines Consumption (2017-2022)

    • 10.8 Oceania Consumption Analysis

      • 10.8.1 Australia Nasal Vaccines Consumption (2017-2022)

      • 10.8.2 New Zealand Nasal Vaccines Consumption (2017-2022)

    11 Global Nasal Vaccines Competitive Analysis

    • 11.1 Serum Institute of India

      • 11.1.1 Serum Institute of India Company Details

      • 11.1.2 Serum Institute of India Nasal Vaccines Sales, Price, Value and Gross Profit (2017-2022)

      • 11.1.3 Serum Institute of India Nasal Vaccines Main Business and Markets Served

      • 11.1.4 Serum Institute of India Nasal Vaccines Product Portfolio

      • 11.1.5 Recent Research and Development Strategies

    • 11.2 GlaxoSmithKline

      • 11.2.1 GlaxoSmithKline Company Details

      • 11.2.2 GlaxoSmithKline Nasal Vaccines Sales, Price, Value and Gross Profit (2017-2022)

      • 11.2.3 GlaxoSmithKline Nasal Vaccines Main Business and Markets Served

      • 11.2.4 GlaxoSmithKline Nasal Vaccines Product Portfolio

      • 11.2.5 Recent Research and Development Strategies

    • 11.3 Bharat Biotech

      • 11.3.1 Bharat Biotech Company Details

      • 11.3.2 Bharat Biotech Nasal Vaccines Sales, Price, Value and Gross Profit (2017-2022)

      • 11.3.3 Bharat Biotech Nasal Vaccines Main Business and Markets Served

      • 11.3.4 Bharat Biotech Nasal Vaccines Product Portfolio

      • 11.3.5 Recent Research and Development Strategies

    • 11.4 PharmaJet and Crossject

      • 11.4.1 PharmaJet and Crossject Company Details

      • 11.4.2 PharmaJet and Crossject Nasal Vaccines Sales, Price, Value and Gross Profit (2017-2022)

      • 11.4.3 PharmaJet and Crossject Nasal Vaccines Main Business and Markets Served

      • 11.4.4 PharmaJet and Crossject Nasal Vaccines Product Portfolio

      • 11.4.5 Recent Research and Development Strategies

    • 11.5 BioDiem

      • 11.5.1 BioDiem Company Details

      • 11.5.2 BioDiem Nasal Vaccines Sales, Price, Value and Gross Profit (2017-2022)

      • 11.5.3 BioDiem Nasal Vaccines Main Business and Markets Served

      • 11.5.4 BioDiem Nasal Vaccines Product Portfolio

      • 11.5.5 Recent Research and Development Strategies

    • 11.6 Abbott

      • 11.6.1 Abbott Company Details

      • 11.6.2 Abbott Nasal Vaccines Sales, Price, Value and Gross Profit (2017-2022)

      • 11.6.3 Abbott Nasal Vaccines Main Business and Markets Served

      • 11.6.4 Abbott Nasal Vaccines Product Portfolio

      • 11.6.5 Recent Research and Development Strategies

    • 11.7 AstraZeneca

      • 11.7.1 AstraZeneca Company Details

      • 11.7.2 AstraZeneca Nasal Vaccines Sales, Price, Value and Gross Profit (2017-2022)

      • 11.7.3 AstraZeneca Nasal Vaccines Main Business and Markets Served

      • 11.7.4 AstraZeneca Nasal Vaccines Product Portfolio

      • 11.7.5 Recent Research and Development Strategies

    • 11.8 Antares Pharma

      • 11.8.1 Antares Pharma Company Details

      • 11.8.2 Antares Pharma Nasal Vaccines Sales, Price, Value and Gross Profit (2017-2022)

      • 11.8.3 Antares Pharma Nasal Vaccines Main Business and Markets Served

      • 11.8.4 Antares Pharma Nasal Vaccines Product Portfolio

      • 11.8.5 Recent Research and Development Strategies

    • 11.9 Sanofi

      • 11.9.1 Sanofi Company Details

      • 11.9.2 Sanofi Nasal Vaccines Sales, Price, Value and Gross Profit (2017-2022)

      • 11.9.3 Sanofi Nasal Vaccines Main Business and Markets Served

      • 11.9.4 Sanofi Nasal Vaccines Product Portfolio

      • 11.9.5 Recent Research and Development Strategies

    • 11.10 INJEX Pharma GmbH

      • 11.10.1 INJEX Pharma GmbH Company Details

      • 11.10.2 INJEX Pharma GmbH Nasal Vaccines Sales, Price, Value and Gross Profit (2017-2022)

      • 11.10.3 INJEX Pharma GmbH Nasal Vaccines Main Business and Markets Served

      • 11.10.4 INJEX Pharma GmbH Nasal Vaccines Product Portfolio

      • 11.10.5 Recent Research and Development Strategies

    12 Global Nasal Vaccines Market Outlook by Types and Applications to 2028

    • 12.1 Global Nasal Vaccines Consumption Forecast and Growth Rate by Type (2022-2028)

      • 12.1.1 Global Flu Vaccines Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.2 Global COVID-19 Vaccines Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.3 Global Other Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • 12.2 Global Nasal Vaccines Consumption Forecast and Growth Rate by Application (2022-2028)

      • 12.2.1 Global Adult Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.2 Global Children Consumption Forecast and Growth Rate (2022-2028)

    13 Country-wise Nasal Vaccines Market Analysis and Outlook to 2028

    • 13.1 Global Nasal Vaccines Consumption Forecast (2022-2028)

    • 13.2 North America Consumption Analysis

      • 13.2.1 United States Nasal Vaccines Consumption Forecast (2022-2028)

      • 13.2.2 Canada Nasal Vaccines Consumption Forecast (2022-2028)

      • 13.2.3 Mexico Nasal Vaccines Consumption Forecast (2022-2028)

    • 13.3 Europe Consumption Analysis

      • 13.3.1 Germany Nasal Vaccines Consumption Forecast (2022-2028)

      • 13.3.2 UK Nasal Vaccines Consumption Forecast (2022-2028)

      • 13.3.3 Spain Nasal Vaccines Consumption Forecast (2022-2028)

      • 13.3.4 Belgium Nasal Vaccines Consumption Forecast (2022-2028)

      • 13.3.5 France Nasal Vaccines Consumption Forecast (2022-2028)

      • 13.3.6 Italy Nasal Vaccines Consumption Forecast (2022-2028)

      • 13.3.7 Denmark Nasal Vaccines Consumption Forecast (2022-2028)

      • 13.3.8 Finland Nasal Vaccines Consumption Forecast (2022-2028)

      • 13.3.9 Norway Nasal Vaccines Consumption Forecast (2022-2028)

      • 13.3.10 Sweden Nasal Vaccines Consumption Forecast (2022-2028)

      • 13.3.11 Poland Nasal Vaccines Consumption Forecast (2022-2028)

      • 13.3.12 Russia Nasal Vaccines Consumption Forecast (2022-2028)

      • 13.3.13 Turkey Nasal Vaccines Consumption Forecast (2022-2028)

    • 13.4 APAC Consumption Analysis

      • 13.4.1 China Nasal Vaccines Consumption Forecast (2022-2028)

      • 13.4.2 Japan Nasal Vaccines Consumption Forecast (2022-2028)

      • 13.4.3 India Nasal Vaccines Consumption Forecast (2022-2028)

      • 13.4.4 South Korea Nasal Vaccines Consumption Forecast (2022-2028)

      • 13.4.5 Pakistan Nasal Vaccines Consumption Forecast (2022-2028)

      • 13.4.6 Bangladesh Nasal Vaccines Consumption Forecast (2022-2028)

      • 13.4.7 Indonesia Nasal Vaccines Consumption Forecast (2022-2028)

      • 13.4.8 Thailand Nasal Vaccines Consumption Forecast (2022-2028)

      • 13.4.9 Singapore Nasal Vaccines Consumption Forecast (2022-2028)

      • 13.4.10 Malaysia Nasal Vaccines Consumption Forecast (2022-2028)

      • 13.4.11 Philippines Nasal Vaccines Consumption Forecast (2022-2028)

      • 13.4.12 Vietnam Nasal Vaccines Consumption Forecast (2022-2028)

    • 13.5 South America Consumption Analysis

      • 13.5.1 Brazil Nasal Vaccines Consumption Forecast (2022-2028)

      • 13.5.2 Colombia Nasal Vaccines Consumption Forecast (2022-2028)

      • 13.5.3 Chile Nasal Vaccines Consumption Forecast (2022-2028)

      • 13.5.4 Argentina Nasal Vaccines Consumption Forecast (2022-2028)

      • 13.5.5 Venezuela Nasal Vaccines Consumption Forecast (2022-2028)

      • 13.5.6 Peru Nasal Vaccines Consumption Forecast (2022-2028)

      • 13.5.7 Puerto Rico Nasal Vaccines Consumption Forecast (2022-2028)

      • 13.5.8 Ecuador Nasal Vaccines Consumption Forecast (2022-2028)

    • 13.6 GCC Consumption Analysis

      • 13.6.1 Bahrain Nasal Vaccines Consumption Forecast (2022-2028)

      • 13.6.2 Kuwait Nasal Vaccines Consumption Forecast (2022-2028)

      • 13.6.3 Oman Nasal Vaccines Consumption Forecast (2022-2028)

      • 13.6.4 Qatar Nasal Vaccines Consumption Forecast (2022-2028)

      • 13.6.5 Saudi Arabia Nasal Vaccines Consumption Forecast (2022-2028)

      • 13.6.6 United Arab Emirates Nasal Vaccines Consumption Forecast (2022-2028)

    • 13.7 Africa Consumption Analysis

      • 13.7.1 Nigeria Nasal Vaccines Consumption Forecast (2022-2028)

      • 13.7.2 South Africa Nasal Vaccines Consumption Forecast (2022-2028)

      • 13.7.3 Egypt Nasal Vaccines Consumption Forecast (2022-2028)

      • 13.7.4 Algeria Nasal Vaccines Consumption Forecast (2022-2028)

    • 13.8 Oceania Consumption Analysis

      • 13.8.1 Australia Nasal Vaccines Consumption Forecast (2022-2028)

      • 13.8.2 New Zealand Nasal Vaccines Consumption Forecast (2022-2028)

    14 Conclusions


    The List of Tables and Figures

    • Table Definition of Nasal Vaccines

    • Figure of Nasal Vaccines Picture

    • Table Global Nasal Vaccines Import by Region (Top 10 Countries) (2017-2028)

    • Table Global Nasal Vaccines Export by Region (Top 10 Countries) (2017-2028)

    • Figure Global Flu Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Global COVID-19 Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Global Other Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Global Adult Consumption and Growth Rate (2017-2022)

    • Figure Global Children Consumption and Growth Rate (2017-2022)

    • Figure Global Nasal Vaccines Consumption by Country (2017-2022)

    • Table North America Nasal Vaccines Consumption by Country (2017-2022)

    • Figure United States Nasal Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Canada Nasal Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Mexico Nasal Vaccines Consumption and Growth Rate (2017-2022)

    • Table Europe Nasal Vaccines Consumption by Country (2017-2022)

    • Figure Germany Nasal Vaccines Consumption and Growth Rate (2017-2022)

    • Figure UK Nasal Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Spain Nasal Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Belgium Nasal Vaccines Consumption and Growth Rate (2017-2022)

    • Figure France Nasal Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Italy Nasal Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Denmark Nasal Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Finland Nasal Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Norway Nasal Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Sweden Nasal Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Poland Nasal Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Russia Nasal Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Turkey Nasal Vaccines Consumption and Growth Rate (2017-2022)

    • Table APAC Nasal Vaccines Consumption by Country (2017-2022)

    • Figure China Nasal Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Japan Nasal Vaccines Consumption and Growth Rate (2017-2022)

    • Figure India Nasal Vaccines Consumption and Growth Rate (2017-2022)

    • Figure South Korea Nasal Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Pakistan Nasal Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Bangladesh Nasal Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Indonesia Nasal Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Thailand Nasal Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Singapore Nasal Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Malaysia Nasal Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Philippines Nasal Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Vietnam Nasal Vaccines Consumption and Growth Rate (2017-2022)

    • Table South America Nasal Vaccines Consumption by Country (2017-2022)

    • Figure Brazil Nasal Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Colombia Nasal Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Chile Nasal Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Argentina Nasal Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Venezuela Nasal Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Peru Nasal Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Puerto Rico Nasal Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Ecuador Nasal Vaccines Consumption and Growth Rate (2017-2022)

    • Table GCC Nasal Vaccines Consumption by Country (2017-2022)

    • Figure Bahrain Nasal Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Kuwait Nasal Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Oman Nasal Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Qatar Nasal Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Saudi Arabia Nasal Vaccines Consumption and Growth Rate (2017-2022)

    • Figure United Arab Emirates Nasal Vaccines Consumption and Growth Rate (2017-2022)

    • Table Africa Nasal Vaccines Consumption by Country (2017-2022)

    • Figure Nigeria Nasal Vaccines Consumption and Growth Rate (2017-2022)

    • Figure South Africa Nasal Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Egypt Nasal Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Algeria Nasal Vaccines Consumption and Growth Rate (2017-2022)

    • Table Oceania Nasal Vaccines Consumption by Country (2017-2022)

    • Figure Australia Nasal Vaccines Consumption and Growth Rate (2017-2022)

    • Figure New Zealand Nasal Vaccines Consumption and Growth Rate (2017-2022)

    • Table Serum Institute of India Company Details

    • Table Serum Institute of India Nasal Vaccines Sales, Price, Value and Gross Profit (2017-2022)

    • Table Serum Institute of India Nasal Vaccines Main Business and Markets Served

    • Table Serum Institute of India Nasal Vaccines Product Portfolio

    • Table GlaxoSmithKline Company Details

    • Table GlaxoSmithKline Nasal Vaccines Sales, Price, Value and Gross Profit (2017-2022)

    • Table GlaxoSmithKline Nasal Vaccines Main Business and Markets Served

    • Table GlaxoSmithKline Nasal Vaccines Product Portfolio

    • Table Bharat Biotech Company Details

    • Table Bharat Biotech Nasal Vaccines Sales, Price, Value and Gross Profit (2017-2022)

    • Table Bharat Biotech Nasal Vaccines Main Business and Markets Served

    • Table Bharat Biotech Nasal Vaccines Product Portfolio

    • Table PharmaJet and Crossject Company Details

    • Table PharmaJet and Crossject Nasal Vaccines Sales, Price, Value and Gross Profit (2017-2022)

    • Table PharmaJet and Crossject Nasal Vaccines Main Business and Markets Served

    • Table PharmaJet and Crossject Nasal Vaccines Product Portfolio

    • Table BioDiem Company Details

    • Table BioDiem Nasal Vaccines Sales, Price, Value and Gross Profit (2017-2022)

    • Table BioDiem Nasal Vaccines Main Business and Markets Served

    • Table BioDiem Nasal Vaccines Product Portfolio

    • Table Abbott Company Details

    • Table Abbott Nasal Vaccines Sales, Price, Value and Gross Profit (2017-2022)

    • Table Abbott Nasal Vaccines Main Business and Markets Served

    • Table Abbott Nasal Vaccines Product Portfolio

    • Table AstraZeneca Company Details

    • Table AstraZeneca Nasal Vaccines Sales, Price, Value and Gross Profit (2017-2022)

    • Table AstraZeneca Nasal Vaccines Main Business and Markets Served

    • Table AstraZeneca Nasal Vaccines Product Portfolio

    • Table Antares Pharma Company Details

    • Table Antares Pharma Nasal Vaccines Sales, Price, Value and Gross Profit (2017-2022)

    • Table Antares Pharma Nasal Vaccines Main Business and Markets Served

    • Table Antares Pharma Nasal Vaccines Product Portfolio

    • Table Sanofi Company Details

    • Table Sanofi Nasal Vaccines Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sanofi Nasal Vaccines Main Business and Markets Served

    • Table Sanofi Nasal Vaccines Product Portfolio

    • Table INJEX Pharma GmbH Company Details

    • Table INJEX Pharma GmbH Nasal Vaccines Sales, Price, Value and Gross Profit (2017-2022)

    • Table INJEX Pharma GmbH Nasal Vaccines Main Business and Markets Served

    • Table INJEX Pharma GmbH Nasal Vaccines Product Portfolio

    • Figure Global Flu Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global COVID-19 Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Other Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Adult Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Children Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Nasal Vaccines Consumption Forecast by Country (2022-2028)

    • Table North America Nasal Vaccines Consumption Forecast by Country (2022-2028)

    • Figure United States Nasal Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Canada Nasal Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Mexico Nasal Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Nasal Vaccines Consumption Forecast by Country (2022-2028)

    • Figure Germany Nasal Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure UK Nasal Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Spain Nasal Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Belgium Nasal Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure France Nasal Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Italy Nasal Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Denmark Nasal Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Finland Nasal Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Norway Nasal Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Sweden Nasal Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Poland Nasal Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Russia Nasal Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Turkey Nasal Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Table APAC Nasal Vaccines Consumption Forecast by Country (2022-2028)

    • Figure China Nasal Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Nasal Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Nasal Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Nasal Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Pakistan Nasal Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Bangladesh Nasal Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Indonesia Nasal Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Thailand Nasal Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Singapore Nasal Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Malaysia Nasal Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Philippines Nasal Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Vietnam Nasal Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Table South America Nasal Vaccines Consumption Forecast by Country (2022-2028)

    • Figure Brazil Nasal Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Colombia Nasal Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Chile Nasal Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Argentina Nasal Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Venezuela Nasal Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Peru Nasal Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Puerto Rico Nasal Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Ecuador Nasal Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Table GCC Nasal Vaccines Consumption Forecast by Country (2022-2028)

    • Figure Bahrain Nasal Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Kuwait Nasal Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Oman Nasal Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Qatar Nasal Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Saudi Arabia Nasal Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure United Arab Emirates Nasal Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Table Africa Nasal Vaccines Consumption Forecast by Country (2022-2028)

    • Figure Nigeria Nasal Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Africa Nasal Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Egypt Nasal Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Algeria Nasal Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Table Oceania Nasal Vaccines Consumption Forecast by Country (2022-2028)

    • Figure Australia Nasal Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure New Zealand Nasal Vaccines Consumption Forecast and Growth Rate (2022-2028)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US